SUMOylation is a regulator of the translocation of Jak2 between nucleus and cytosol (Q44263714)

1 December 2017

title

SUMOylation is a regulator of the translocation of Jak2 between nucleus and cytosol (English)

1 reference

1 December 2017

1 reference

Magdalena Sedek

1

1 reference

1 December 2017

Ger J Strous

series ordinal

2

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 July 2013

1 reference

1 December 2017

1 reference

1 December 2017

volume

453

1 reference

1 December 2017

issue

2

1 reference

1 December 2017

page(s)

231-239

1 reference

Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121375

JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121375

Preferential nuclear accumulation of JAK2V617F in CD34+ but not in granulocytic, megakaryocytic, or erythroid cells of patients with Philadelphia-negative myeloproliferative neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121375

Concepts in sumoylation: a decade on

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121375

The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121375

Site-specific identification of SUMO-2 targets in cells reveals an inverted SUMOylation motif and a hydrophobic cluster SUMOylation motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121375

A recurrent phospho-sumoyl switch in transcriptional repression and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121375

Phosphorylation of serine 303 is a prerequisite for the stress-inducible SUMO modification of heat shock factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121375

Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121375

SUMO and Transcriptional Repression: Dynamic Interactions Between the MAP Kinase and SUMO Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121375

Opposed regulation of corepressor CtBP by SUMOylation and PDZ binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121375

Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121375

SUMOylation mediates the nuclear translocation and signaling of the IGF-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121375

Regulated SUMOylation and ubiquitination of DdMEK1 is required for proper chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121375

Small ubiquitin-like modifier conjugation regulates nuclear export of TEL, a putative tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121375

The signal transduction of the growth hormone receptor is regulated by the ubiquitin/proteasome system and continues after endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121375

Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121375

SUMOylation of nuclear actin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121375

Jak2 is a negative regulator of ubiquitin-dependent endocytosis of the growth hormone receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121375

Increased protein SUMOylation following focal cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121375

SUMOylation participates in induction of ischemic tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121375

Sumo-2/3-ylation following in vitro modeled ischemia is reduced in delayed ischemic tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121375

Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121375

Transient global cerebral ischemia induces a massive increase in protein sumoylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121375

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121375

A gain-of-function mutation of JAK2 in myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121375

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121375

Identification of an acquired JAK2 mutation in polycythemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20121375

21 January 2018

Identifiers

DOI

10.1042/BJ20121375

1 reference

1 December 2017

1 reference